Indeed, vaccination with cDC1s isolated from LLC-OVA tumours conferred a better protection than cDC2 vaccination (Fig. 10a), which correlated with a significantly augmented infiltration of CD8+ T cells in the former (Fig. 10b). This evidence concerns the gene CD8A and neoplasm.